Neuraly and Enigma Biomedical have signed an agreement for PMI04, a positron emission tomography (PET) imaging biomarker for neuroinflammation. Enigma will acquire an exclusive research license for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback